Machine Learning Boosts CHO Cell Bioprocessing for Higher Yield and Quality

A recent paper in Biotechnology Journal (2025) explores how machine learning can optimize Chinese hamster ovary (CHO) cell bioprocesses and media formulations to improve both antibody titer and glycosylation patterns. The study, titled "Toward Machine Learning-Guided CHO Bioprocess and Media Optimization for Improved Titer and Glycosylation," leverages AI to predict optimal culture conditions, reducing the need for exhaustive trial-and-error experiments. By training models on historical data, the approach identifies key media components and process parameters that enhance productivity while maintaining desired glycan profiles—a critical factor for therapeutic protein efficacy. This work highlights the growing role of data-driven methods in biomanufacturing, potentially accelerating the development of cost-effective biologics.